Synthetic Cannabinoids and Seizures: The Neurological Risks Behind K2, Spice and Herbal Incense Blends

Among the many acute harms associated with K2, Spice and similar herbal incense products, seizures stand out as one of the most frightening and least understood. Unlike the drowsiness or euphoria many users expect from cannabis, synthetic cannabinoid toxicity can produce generalised convulsions, muscle rigidity and loss of consciousness within minutes of exposure. Understanding why this happens requires looking at how these compounds interact with the endocannabinoid system — and why their pharmacology differs so sharply from THC.

Why Synthetic Cannabinoids Can Trigger Seizures

Seizures linked to synthetic cannabinoids are not a rare idiosyncratic reaction. They are a predictable consequence of how these molecules behave at the CB1 receptor, the primary cannabinoid receptor in the central nervous system. THC acts as a partial agonist at CB1 — it activates the receptor, but only to a limited degree, which creates a natural ceiling on its effects. Many synthetic cannabinoids, by contrast, are full agonists with binding affinities several times higher than THC.

That difference matters enormously. When a full agonist floods CB1 receptors throughout the cortex, hippocampus and basal ganglia, the excitatory-inhibitory balance in the brain can be disrupted. Glutamate signalling becomes dysregulated, GABAergic inhibition is overwhelmed, and the result can be a generalised seizure. In clinical case series from UK emergency departments and European poison centres, convulsions are consistently reported among the most common severe presentations of synthetic cannabinoid toxicity.

The Role of Potency and Dose Uncertainty

Compounding the pharmacological risk is the practical reality of dosing. Because synthetic cannabinoids are active at milligram or even microgram levels, the difference between a manageable dose and a seizure-inducing dose is extraordinarily narrow. In infused herbal blends, the compound is rarely distributed evenly across plant material. One pinch of a K2 or Spice blend may contain almost nothing; the next may contain several times the threshold for convulsions.

This unpredictability is one reason why synthetic cannabinoid products carry risks that do not apply to plant cannabis in the same way. Users cannot titrate a dose they cannot measure, and the product itself offers no reliable indication of how much active compound any given portion contains.

Which Compounds Are Most Associated With Convulsions

The JWH series, including JWH-018 and JWH-073, were among the first synthetic cannabinoids detected in herbal incense blends and remain associated with seizure reports. As the market evolved, newer generations of compounds — including 5F-AKB-48, 5F-APINACA and various indazole carboxamides — have appeared in products sold under names like Cloud Nine, AK-47 and Black Mamba. Many of these are significantly more potent than their predecessors.

Research published in clinical toxicology journals has documented that seizure risk tends to track with CB1 affinity and efficacy rather than with the specific chemical family. In other words, the more completely a compound activates CB1, the greater the potential for neurological destabilisation. This is why synthetic cannabinoid pharmacology is central to understanding the clinical picture.

Adulteration and Unknown Mixtures

Seizure risk is amplified when products contain multiple synthetic cannabinoids, or when they are contaminated with other pharmacological agents. Analytical surveys of seized herbal incense samples in the UK and across Europe have repeatedly found products containing two, three or more different synthetic cannabinoids, sometimes alongside synthetic cathinones or benzodiazepine analogues. These combinations can produce unpredictable interactions, and some adulterants lower the seizure threshold independently.

Recognising a Synthetic Cannabinoid Seizure

Clinicians and harm-reduction services describe a recognisable pattern in severe synthetic cannabinoid toxicity. Warning signs may include:

• Sudden muscle rigidity or jerking movements, particularly in the limbs
• Confusion, agitation or a trance-like state before convulsions begin
• Loss of consciousness with or without incontinence
• Profuse sweating, tachycardia and elevated blood pressure
• Post-ictal confusion lasting longer than expected after a typical seizure

In some cases, seizures are preceded by a period of extreme anxiety, paranoia or a sensation of impending doom. In others, convulsions occur without obvious warning. Bystanders should never attempt to restrain a person having a seizure or place anything in their mouth. Emergency services should be called immediately, and the person should be positioned safely on their side once movements stop.

Are the Neurological Effects Permanent?

This is one of the most important open questions in synthetic cannabinoid education. The short answer is that the evidence is still developing, but there are reasons for concern. Repeated seizures — particularly prolonged or clustered episodes — can cause excitotoxic injury to hippocampal neurons, a region critical for memory and learning. Some case reports describe persistent cognitive deficits, memory problems and mood instability in individuals who experienced severe synthetic cannabinoid toxicity.

There is also the question of kindling, a phenomenon in which repeated seizures lower the threshold for future seizures. For individuals with a pre-existing seizure disorder, or those taking medications that affect seizure threshold, the risk is substantially higher. Anyone with a personal or family history of epilepsy should treat synthetic cannabinoid exposure as a particularly serious hazard.

Interaction With Other Substances

Alcohol, stimulants, certain antidepressants and sleep deprivation can all lower the seizure threshold. When combined with a potent full-agonist cannabinoid, the cumulative risk is not simply additive. This is one reason why harm-reduction organisations in the UK and EU advise against mixing synthetic cannabinoid products with other psychoactive substances, even those considered relatively benign in isolation.

What UK and EU Data Show

Reports from the European Monitoring Centre for Drugs and Drug Addiction and from UK hospital trusts consistently place neurological symptoms — including seizures, agitation and reduced consciousness — among the leading reasons for emergency presentation linked to synthetic cannabinoids. In some surveillance years, seizures have accounted for a significant proportion of severe cases, particularly among younger users and those using high-potency infused products.

The pattern is not confined to any single product line or brand. Whether the product is sold as K2 liquid spray, infused paper, or a traditional herbal blend, the underlying pharmacological risk is the same. What varies is the concentration and the specific compounds present — factors that are rarely disclosed on packaging.

Harm Reduction and Clinical Response

For anyone who chooses to use these products despite the documented risks, several principles reduce — though never eliminate — the danger:

• Start with the smallest possible amount and wait before considering more
• Avoid using alone, so that someone can call for help if a seizure occurs
• Do not combine with alcohol, stimulants or other drugs
• Be aware that the same product can vary dramatically in potency between batches
• Seek immediate medical attention for any seizure, even if it appears to resolve quickly

Clinically, management of synthetic cannabinoid-induced seizures follows standard seizure protocols, with benzodiazepines as first-line treatment. Because the underlying cause is pharmacological rather than structural, most acute seizures resolve with supportive care — but the risk of recurrence during the same episode remains elevated, and observation is typically required.

Frequently Asked Questions

Can synthetic cannabinoids cause seizures in first-time users?

Yes. Seizures have been reported in individuals with no prior history of epilepsy and no previous exposure to synthetic cannabinoids. Potency and individual susceptibility both play a role, and there is no reliable way to predict who will be affected.

How quickly do seizures occur after use?

In reported cases, seizures typically occur within minutes to a few hours of exposure. When products are smoked or vaporised, onset tends to be faster than with oral consumption.

Are K2 and Spice more likely to cause seizures than cannabis?

The available evidence suggests yes. THC is a partial CB1 agonist with a built-in ceiling on its effects, whereas many synthetic cannabinoids are full agonists at far higher potency. This pharmacological difference is widely considered the main reason seizure reports cluster around synthetic products rather than plant cannabis.

Do seizures mean permanent brain damage?

Not necessarily. Many people recover fully after a single episode. However, repeated or prolonged seizures carry a risk of neurological injury, and some individuals report lasting cognitive or mood changes following severe toxicity. Anyone who has experienced a synthetic cannabinoid-related seizure should seek neurological assessment.

What should I do if someone has a seizure after using herbal incense?

Call emergency services immediately. Do not restrain the person or put anything in their mouth. Clear the area of hard objects, cushion the head, and once movements stop, place them on their side to keep the airway clear. Stay with them until help arrives.

Conclusion

Seizures are one of the clearest signals that synthetic cannabinoids act on the brain in ways that differ fundamentally from THC. The combination of full CB1 agonism, extreme potency, inconsistent dosing and frequent adulteration creates a neurological risk profile that is difficult to overstate. For researchers, clinicians and policymakers, seizure data offer a useful lens on the broader harms of the synthetic cannabinoid market. For anyone encountering these products, the message is straightforward: the risk of convulsions is real, unpredictable and not limited to heavy or long-term users.